Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
出版年份 2016 全文链接
标题
Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 115, Issue 1, Pages 59-65
出版商
Springer Nature
发表日期
2016-06-10
DOI
10.1038/bjc.2016.175
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pancreatic Adenocarcinoma, Version 2.2014
- (2017) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- Cell-free DNA as a novel marker in cancer therapy
- (2015) Shumei Kato et al. Biomarkers in Medicine
- Detection ofK-rasgene mutation by liquid biopsy in patients with pancreatic cancer
- (2015) Hideaki Kinugasa et al. CANCER
- Unique features of mutations revealed by sequentially reprogrammed induced pluripotent stem cells
- (2015) Shuai Gao et al. Nature Communications
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
- (2015) Mark Sausen et al. Nature Communications
- Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
- (2015) Erina Takai et al. Scientific Reports
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
- (2014) Kyongchol Kim et al. Annals of Surgical Treatment and Research
- The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
- (2013) A D Nygaard et al. BRITISH JOURNAL OF CANCER
- Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
- (2013) Andrew D. Rhim et al. GASTROENTEROLOGY
- KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer
- (2013) Stefan Boeck et al. JOURNAL OF GASTROENTEROLOGY
- Absolute quantification by droplet digital PCR versus analog real-time PCR
- (2013) Christopher M Hindson et al. NATURE METHODS
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening for Pancreatic Cancer
- (2012) Katherine E. Poruk et al. ANNALS OF SURGERY
- Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
- (2012) D. Hashad et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
- (2012) Takeshi Ogura et al. JOURNAL OF GASTROENTEROLOGY
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
- (2011) Benjamin J. Hindson et al. ANALYTICAL CHEMISTRY
- Circulating tumour markers can define patients with normal colons, benign polyps and cancers
- (2011) R Mead et al. BRITISH JOURNAL OF CANCER
- Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer
- (2011) Leticia De Mattos-Arruda et al. Future Oncology
- Plasma cell-free DNA in ovarian cancer
- (2010) Aparna A. Kamat et al. CANCER
- K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer
- (2010) H. Chen et al. EJSO
- Coordinated Epidermal Growth Factor Receptor Pathway Gene Overexpression Predicts Epidermal Growth Factor Receptor Inhibitor Sensitivity in Pancreatic Cancer
- (2008) A. Jimeno et al. CANCER RESEARCH
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started